Percutaneous mitral balloon valvuloplasty is safe for pregnant women with congestive heart failure due to rheumatic mitral stenosis and has a low morbidity and mortality risk for their infants.
Percutaneous mitral balloon valvuloplasty is safe for pregnant women with congestive heart failure due to rheumatic mitral stenosis and has a low morbidity and mortality risk for their infants.
Cesar A. Esteves, MD, PhD, of the Institute Dante Pazzanese of Cardiology, in Sao Paolo, Brazil, and colleagues studied the procedure in 71 pregnant women with severe rheumatic mitral stenosis and congestive heart failure.
The researchers found the procedure worked well in all cases, causing the mitral valve area to expand from 0.9 to 2 cm2 . Ninety-eight percent of patients reached normal or near-normal heart function by delivery.
"Percutaneous mitral balloon valvuloplasty is safe and effective, has a low morbidity and mortality rate for the mother and the fetus, and has favorable long-term results in pregnant women with rheumatic mitral stenosis in New York Heart Association functional class III or IV," the authors wrote.
Esteves CA, Munoz JS, Braga S, et al. Immediate and long-term follow-up of percutaneous balloon mitral valvuloplasty in pregnant patients with rheumatic mitral stenosis. Am J Cardiol. 2006;98:812-816.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More